Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
Submitted by
admin
on November 3, 2021 - 10:39am
Source:
Motley Fool
News Tags:
Bristol Myers Squibb
Aurinia Pharmaceuticals
M&A
Headline:
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
snippet:
Biopharma merger agreements tend to happen fast once news of talks leaks to the public.
Aurinia Pharmaceuticals has yet to get a formal bid from any of its rumored suitors.
This key issue might be the reason for the delay.
Do Not Allow Advertisers to Use My Personal information
